Noteworthy, it has been reported that the JAK2 mutation, at the center of the MPN pathogenesis, activates the STAT3 signaling pathway, which is involved in a variety of inflammatory cytokines expressions causing inflammation and dysfunction of the immune system [28]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.